|
|
Email: gerald_hladik@med.unc.edu |
|---|
Gerald Hladik, MD
Clinical Professor of Medicine; Medical Director, Acute Dialysis Unit, UNC Hospitals; Director, Nephrology Training Program
Specialty Areas: Acute and chronic kidney disease; Electrolyte and acid-base disorders; Medical education.
Chronology:
BA Summa Cum Laude with Distinction in Biology: Boston University, 1985; MD Magna Cum Laude: Boston University, 1989; Internal Medicine Resident: University of North Carolina, 1989-92; Clinical Instructor in Medicine: University of North Carolina, 1992-4; Nephrology Fellow: University of North Carolina, 1994-6; Clinical Assistant Professor of Medicine: University of North Carolina, 1996-2003; Clinical Associate Professor of Medicine 2003-2009; Clinical Professor of Medicine 2009-present. Medical Director: UNC Hospitals Acute Dialysis Program, 1996-Present; Medical Director: Carolina Dialysis-Carrboro, 1996-2009; Course Director: Urinary System Course, 1998-present. Nephrology (Internal Medicine) Training Program Director 2009-present.
Dr. Hladik’s clinical interest is in the evaluation of acute and chronic kidney disease, as well as in the diagnosis and management of complex electrolyte disorders. His academic interest is in medical education. He serves as course director for the second year medical student course in kidney pathophysiology, as well as on a number of committees at UNC and nationally directed toward improving education in nephrology.
Selected Bibliography: Hladik GA. Acute Kidney Injury and Chronic Kidney Disease in Medical Knowledge and Self-Assessment Program 15, Philadelphia, Pa: American College of Physicians, 2009. Hladik GA: Chronic kidney disease. In Netter’s Internal Medicine, 2nd ed., Runge MA and Greganti MA, ed. Philadelphia, Pa: Elsevier; 975-983, 2007. Hladik GA. Acute Renal Failure in Medical Knowledge and Self-Assessment Program 14, Philadelphia, Pa: American College of Physicians, 39-48, 2006. Joy MS and Hladik GA: Disorders of sodium, water, calcium, and phosphorus. In Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG and Posey LM, ed. Pharmacotherpy: A pathophysiologic approach, 5th ed. New York: McGraw Hill, 953-980, 2002. Joy MS, Denu-Ciocca C, Phillips T, Hogan SL and Hladik GA: Lipids in chronic hemodialysis patients: demographic differences and associations with albumin and homocysteine. J Am Soc Nephrol 10: 245A, 1999. Finn WF, Joy MS, Hladik GA, and the Lanthanum Study Group: Results of a randomized dose-ranging, placebo controlled study of lanthanum carbonate for reduction of serum phosphate in chronic renal failure patients receiving hemodialysis. J Am Soc Nephrol 10: 261A, 1999. Finn WF, Joy MS, Hladik GA, and the Lanthanum Study Group: Safety of an investigational phosphate binder (lanthanum carbonate) in hemodialysis patients. J Am Soc Nephrol 10: 231A, 1999. Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Yoursi BM, Cohen RM and Coburn JW: The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13: 1017-1024, 2002. Tawney KW, Tawney PJW, Hladik GA, Hogan SL, Moore DT, and Falk RJ: The Life Readiness Program: a rehabilitation program for end-stage renal disease patients on hemodialysis. J Am Soc Nephrol 10: 270A, 1999. Click here for a list of publications on PubMed.
Back to Faculty & Staff Profiles Page
|
